StockTipsArenaBeta

BUY Rainbow Childrens Medicare Limited — Axis Securities

BUYRainbow Childrens Medicare Limited
Rainbow Childrens Medicare share price target & all analyst calls

byAxis SecuritiesHorizon: NA (inferred 1 year)30 Sept 2025via Institutional / Brokerage Research

Entry₹1,356Inferred
Target₹1,625
Total upside +19.84% (call closed)
Stop lossNot given
At expiry₹1,367.830 Sept 2026, 3:30 pm
Expired+0.87%
Follow Axis Securities for new calls(70% target hit, 813 closed calls)Get alertsWatch RAINBOW for new buy/sell callsGet alertsSee 5 active Long-term calls on RAINBOWSee 274 active Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 30 Sept 2026
14 supporting4 neutral2 opposing
Supports the BUY call (14)

Rainbow Children's Medicare Ltd has executed a lease agreement with the Andhra Pradesh Capital Region Development Authority (APCRDA) for a new facility.

BSE · Company Update·30 Sept · today

(opens in new tab)

5 other SEBI-registered advisors have active long-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · same horizon·28 Sept · yesterday

Rainbow Children's Medicare Ltd appointed Mr. Sudarshan Patodia as the Chief Financial Officer (KMP) and addressed other general matters during its Board Meeting.

BSE · Others·23 Sept · 6d ago

(opens in new tab)

Mr. Sudarshan Patodia has been appointed as the Chief Financial Officer (KMP) of the company.

BSE · Company Update·23 Sept · 6d ago

(opens in new tab)

Mr. Sudarshan Patodia appointed as Chief Financial Officer of the company effective September 23, 2026.

NSE · Appointment·23 Sept · 6d ago

(opens in new tab)
Neutral / worth noting (4)

Rainbow Children's Medicare Limited announced the appointment of Mr. Sudarshan Patodia as the Chief Financial Officer (CFO) and Key Managerial Personnel, effective September 23, 2026. The board also a

NSE · Outcome of Board Meeting·23 Sept · 6d ago

(opens in new tab)
Weighs against the BUY call (2)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Rainbow Childrens Medicare

All analyst calls on Rainbow Childrens Medicare

More from Axis Securities

Every call and its outcome